MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer

BACKGROUND: Recent evidence indicated that the aberrant expression of microRNA plays a crucial role in the development of cervical cancer. The overall shorter survival was strongly related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-206), which target B cell lymphoma-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ai-Hua, Qin, Yu-E, Tang, Wen-Fan, Tao, Jing, Song, Hua-mei, Zuo, Manzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466768/
https://www.ncbi.nlm.nih.gov/pubmed/28615991
http://dx.doi.org/10.1186/s12935-017-0431-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466768/
https://www.ncbi.nlm.nih.gov/pubmed/28615991
http://dx.doi.org/10.1186/s12935-017-0431-9

Ejemplares similares